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Background
Nicotinamide phosphoribosyltransferase (NAMPT)/PBEF/
Visfatin exerts multiple functions and has been implicated
in the pathogenesis of rheumatoid arthritis. The expres-
sion of NAMPT is increased during inflammation and is
identified as a novel mediator of innate immunity. To gain
insight into its role in arthritis and given that NAMPT
induces IL-6 expression that is critical for Th17 lympho-
cytes, we hypothesized that NAMPT-stimulated produc-
tion of IL-6 by monocytes might in turn promote Th17
cells.
Materials and methods
siRNA uptake and NAMPT expression were determined
in Ly6Chigh and Ly6Clow monocyte subsets following intra-
venous injection of siRNA against NAMPT (siNAMPT) or
non-targeting siRNA (siCT) formulated with the DMA-
PAP cationic liposome into mice. Mice with established
collagen-induced arthritis (CIA) were treated weekly after
disease onset with siNAMPT or siCT and clinical features
were assessed. T helper cell frequencies, cytokine produc-
tion and percentage of IL-6-producing Ly6Chigh mono-
cytes were analyzed. Using a coculture system consisting
of purified CD14+ monocytes and autologous CD4+
T cells, NAMPT and cytokine production, as well as the
percentage of IL-17-producing CD4+ T cells were deter-
mined following transfection of CD14+ monocytes with
siCT or siNAMPT.
Results
Upon intravenous injection, siRNA was preferentially
engulfed by Ly6Chigh monocytes and siRNA-mediated
silencing of NAMPT expression in Ly6Chigh monocytes
reduced IL-6 production by these cells, mitigated Th17
cell expansion, and inhibited inflammatory features and
CIA progression. Moreover, NAMPT-RNAi-silenced
CD14+ monocytes were found to reduce the percentage of
IL-17-producing CD4+ T cells.
Conclusions
Taken together, our results show that the expression of
NAMPT in Ly6Chigh monocytes promotes Th17 cells.
Our findings provide new mechanistic insight into the
action of NAMPT in arthritis and demonstrate the utility
of targeting disease-causing genes in Ly6Chigh monocytes
for therapeutic intervention in arthritis.
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